Ondansetron ODT Labatec 4 mg, comprimés orodispersibles - 6 Tablette(n) Swissmedic Key 63263001 Registration Holder Labatec Pharma SA Name Ondansetron ODT Labatec 4 mg, comprimés orodispersibles Date of registration 27.08.2014 Introduction of Sequence 27.08.2014 ATC-Classification Ondansetron (A04AA01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.09. Show package size 6 Tablette(n) Index Therapeuticus (Swissmedic) 01.09. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680632630016 Medication Code Synthetika Pharmacode Disponibility
Composition ondansetronum 4 mg, mannitolum, sorbitolum 3.015-8.442 mg, crospovidonum, silica colloidalis anhydrica, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.1 mg, magnesii stearas, aromatica, aspartamum 0.88 mg pro compresso. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Ondansetron 4 mg
BAG: Active Agent Dose Ondansetron 4 mg
Inactive agents Dose Aromatica Aspartame 0.88 mg Cellulosum Microcristallinum Crospovidonum Magnesii Stearas Mannitol Natrii Stearylis Fumaras Pro Compresso Silica Colloidalis Anhydrica Sorbitol 3.015-8.442 mg
Source Data was imported : 04.03.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
